Molecular Insight Pharmaceuticals, Inc.

CIK 1340752 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Molecular Insight Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
May 13, 201115-12B0001193125-11-139043
May 11, 20118-K0001193125-11-136095
May 4, 20118-K0001193125-11-126307
May 4, 2011EFFECT9999999995-11-001382
May 4, 2011EFFECT9999999995-11-001385
May 3, 2011S-8 POS0001193125-11-123876
May 3, 2011S-8 POS0001193125-11-123891
May 3, 2011250001193125-11-123839
May 3, 2011POS AM0001193125-11-123896
May 3, 2011S-8 POS0001193125-11-123870
May 3, 2011S-8 POS0001193125-11-123862
May 3, 2011S-8 POS0001193125-11-123848
May 3, 2011POS AM0001193125-11-123907
Apr 20, 2011SC 13G/A0001442757-11-000012
Apr 20, 20118-K0001193125-11-102933
Mar 28, 2011SC 13G/A0001442757-11-000005
Mar 16, 20118-K0001193125-11-068711
Mar 10, 2011SC 13D/A0001193125-11-062488
Mar 9, 2011SC 13D/A0001102598-11-000049
Mar 9, 2011SC 13D/A0001193125-11-060765
Mar 9, 2011SC 13D/A0000950123-11-023580
Mar 9, 2011SC 13D/A0000905148-11-000608
Mar 8, 20118-K0001193125-11-059182
Feb 24, 2011SC 13D0000929638-11-000213
Feb 22, 20118-K0001193125-11-040560